Silver Crown Royalties Signs Definitive Agreement to Acquire Royalty on Soma Gold's El Bagre Complex

Silver Crown Royalties agreed to acquire a royalty on 90% of payable silver from Soma Gold’s producing El Bagre complex in Colombia for US$10 million. The agreement provides for minimum deliveries totaling 305,500 ounces over approximately five and a half years, then converts to a 7.5% net smelter return royalty for the life of the operation. Silver Crown expects the deal to be immediately accretive, increasing attributable silver ounce revenue by approximately 29% in 2027 and 57% in 2028; the second US$7 million tranche depends on discharge of Soma’s existing security and registration of first-ranking security.

Analysis

The key underwriting issue is not the headline ounce growth but whether Silver Crown can secure an enforceable claim ahead of Soma’s existing financier. Until that lien is discharged and first-ranking security is registered, the first tranche buys only partial royalty exposure; a delayed discharge could leave Silver Crown with a contractual repurchase remedy rather than the intended full security package. The December 31 deadline is therefore the near-term catalyst and the principal downside control to verify, not a routine closing detail.

For Silver Crown (SCRI), a fixed 3% deduction and scheduled minimum deliveries may cushion near-term volume variability, but the royalty remains exposed to El Bagre continuity, Soma’s ability to perform, silver prices, and a mine whose technical information Silver Crown says it has not independently verified. Management’s accretion and ounce-growth claims are forward-looking; confirm them against the royalty schedule, payable-ounce assumptions, and SCRI share count before assigning value. The longer-dated 7.5% NSR tail is harder to value without mine-life and production data.

For Soma (SOMA), monetizing by-product silver can fund operations without selling equity, but it permanently transfers some silver-price upside and adds a claim on asset cash flows. Net benefit depends on how the proceeds are deployed and whether the senior lender releases security on schedule. Immediate share reactions may favor the financing relief; over 1–3 months, lien-release evidence and operating disclosures matter more. Over 6–18 months, delivery performance and silver prices determine whether the royalty is truly accretive to SCRI. A material delay, weaker El Bagre output, or silver-price reversal would undermine the thesis.

Key Decisions for Investors

• SCRI: Treat as a catalyst watch, not an automatic chase. Reassess after confirmation that the senior security is discharged and first-ranking security is registered; before then, size any exposure for counterparty and recovery risk.
• SOMA: Near-term financing relief is constructive, but do not assume the transaction is unambiguously equity-accretive. Track use of proceeds, operating liquidity, and the senior lender’s release; persistent inability to clear the lien would falsify the favorable financing read.
• Before underwriting SCRI’s stated growth, verify the detailed quarterly minimum-delivery schedule, payable-silver assumptions, mine plan/technical report, and share-count impact. If deliveries fall below schedule or operating interruptions threaten payment, reduce exposure; the release alone does not independently establish production durability.
• No high-conviction pair trade from this announcement alone: the transaction is small relative to SCRI’s stated market capitalization, while pricing, current valuations, liquidity, and the companies’ funding needs are not provided. Revisit after the security milestone and next operating disclosure.